Idera Pharmaceuticals, Inc. (IDRA) Narrows Q4 Loss to 24c/Share
Get Alerts IDRA Hot Sheet
Join SI Premium – FREE
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q4 EPS of ($0.24), versus ($0.35) reported last year.
For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.
For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Diana Shipping withdraws bid to acquire Genco Shipping
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share